US20090171413A1 - Implantable device, system including same, and method utilizing same - Google Patents
Implantable device, system including same, and method utilizing same Download PDFInfo
- Publication number
- US20090171413A1 US20090171413A1 US12/203,041 US20304108A US2009171413A1 US 20090171413 A1 US20090171413 A1 US 20090171413A1 US 20304108 A US20304108 A US 20304108A US 2009171413 A1 US2009171413 A1 US 2009171413A1
- Authority
- US
- United States
- Prior art keywords
- implantable device
- mems
- computing device
- implantable
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3785—Electrical supply generated by biological activity or substance, e.g. body movement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36585—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by two or more physical parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
- A61N1/37229—Shape or location of the implanted or external antenna
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
- A61N1/37258—Alerting the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
- A61N1/37282—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data characterised by communication with experts in remote locations using a network
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/028—Microscale sensors, e.g. electromechanical sensors [MEMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36557—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by chemical substances in blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36564—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36578—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
Definitions
- This application discloses an invention which is related, generally and in various embodiments, to an implantable device, a system including the implantable device, and a method utilizing the implantable device.
- acute coronary syndromes include a spectrum of conditions associated with acute myocardial ischemia. These conditions are a major cause of morbidity and mortality around the world. Often, the signs and symptoms related to acute coronary syndromes occur without warning.
- One such symptom, angina pectoris occurs when an area of the heart does not receive enough oxygen-rich blood. For patients with angina pectoris, the patients commonly mistake the symptoms for gastric acid reflux, indigestion, arthritic pain, etc. In other instances, the signs and symptoms related to acute coronary syndromes are not even perceived by the person—the signs and symptoms are “silent”.
- a device may be surgically implanted to monitor pressures within the circulatory system (e.g., within an abdominal aortic aneurysm sac). Although such monitoring provides a certain peace of mind, the device is less than optimal because it does not predict the occurrence of subsequent acute coronary syndromes, and does not provide any treatment of such subsequent acute coronary syndromes.
- the implantable device includes a computing device, a microelectromechanical system (MEMS) pH sensor connected to the computing device, and a communication system connected to the computing device.
- MEMS microelectromechanical system
- the system includes an implantable device, and a communication device connected to the implantable device.
- the implantable device includes a computing device, a microelectromechanical system (MEMS) pH sensor connected to the computing device, and a communication system connected to the computing device.
- MEMS microelectromechanical system
- this application discloses a method, implemented at least in part by a computing device.
- the method includes measuring pH values of an organ with an implanted device, and determining whether organ ischemia exists based on at least one of the measured pH values.
- aspects of the invention may be implemented by a computing device and/or a computer program stored on a computer-readable medium.
- the computer-readable medium may comprise a disk, a device, and/or a propagated signal.
- FIG. 1 illustrates various embodiments of an implantable device
- FIG. 2 illustrates various embodiments of a computing device of the implantable device of FIG. 1 ;
- FIG. 3 illustrates various embodiments of a MEMS pH sensor of the implantable device of FIG. 1 ;
- FIG. 4 illustrates various embodiments of a MEMS pH sensor of the implantable device of FIG. 1 ;
- FIG. 5 illustrates various embodiments of a MEMS pressure sensor of the implantable device of FIG. 1 ;
- FIG. 6 illustrates various embodiments of a communication system of the implantable device of FIG. 1 ;
- FIG. 7 illustrates various embodiments of a volume conduction antenna of the communication system of FIG. 5 ;
- FIG. 8 illustrates various embodiments of a communication system of the implantable device of FIG. 1 ;
- FIG. 9 illustrates various embodiments of a system which includes the implantable device of FIG. 1 ;
- FIG. 10 illustrates various embodiments of a communication device of the system of FIG. 9 ;
- FIG. 11 illustrates various embodiments of a power source of the system of FIG. 9 ;
- FIG. 12 illustrates various embodiments of a power source of the system of FIG. 9 ;
- FIG. 13 illustrates various embodiments of a power source of the system of FIG. 9 ;
- FIG. 14 illustrates various embodiments of a power source of the system of FIG. 9 ;
- FIG. 15 illustrates various embodiments of a method which utilizes the implantable device of FIG. 1 .
- FIG. 1 illustrates various embodiments of an implantable device 10 .
- the implantable device 10 is of a size and configuration which is suitable for implantation on an organ (e.g., heart, brain, liver, kidney, lung, etc.), and may be implanted using a minimally invasive technique.
- the implantable device 10 may be utilized for the detection and treatment of organ ischemia.
- the implantable device 10 includes a computing device 12 , a microelectromechanical system (MEMS) pH sensor 14 , and a communication system 16 .
- MEMS microelectromechanical system
- the implantable device 10 may also include a MEMS pressure sensor 18 , an analysis module 20 , and a power source 22 .
- the computing device 12 may be any suitable type of computing device.
- the computing device 12 is configured as shown in FIG. 2 .
- the computing device 12 includes a processor 24 .
- the processor 24 may be any suitable type of processor (e.g., a microprocessor, a digital signal processor, etc.).
- the computing device 12 also includes a storage device 26 .
- the storage device 26 may be any suitable type of storage device.
- the computing device 12 is configured for direct memory access.
- the MEMS pH sensor 14 is connected to the computing device 12 , and is configured for continuously measuring a pH level (e.g., a pH level of an organ).
- the MEMS pH sensor 14 may be any suitable type of MEMS pH sensor.
- the MEMS pH sensor 14 is configured as shown in FIG. 3 .
- the MEMS pH sensor 14 includes a substrate 28 , a first electrode 30 , a second electrode 32 , a first dielectric layer 34 , a third electrode 36 , a second dielectric layer 38 , an electrolyte layer 40 , a passivation layer 42 , and a liquid junction 44 .
- the liquid junction 44 provides an electrical connection between the electrolyte layer 40 and tissue fluid of the organ of which pH is to be measured (e.g., myocardial tissue fluid, brain tissue fluid, liver tissue fluid, kidney tissue fluid, lung tissue fluid, etc.).
- the first electrode 30 functions as an internal reference electrode, and may include any suitable type of conductor (e.g., gold).
- the second electrode 32 functions as an indicator electrode, and may include any suitable type of conductor (e.g., iridium oxide).
- the third electrode 36 functions as a reference electrode, and may include any suitable type of conductor (e.g., silver, silver chloride).
- the MEMS pH sensor 14 is configured as shown in FIG. 4 .
- the MEMS pH sensor 14 includes a substrate 46 , a first electrode 48 , a second electrode 50 , a plurality of third electrodes 52 , a cover 54 , a fluidic channel 56 , and a liquid junction 58 .
- the plurality of third electrodes 52 and the fluidic channel 56 cooperate to form a microfluidic switch.
- the first electrode 48 functions as an indicating electrode, and may include any suitable type of conductor (e.g., platinum, chromium, titanium, iridium oxide).
- the second electrode 50 functions as a reference electrode, and may include any suitable type of conductor (e.g., platinum, chromium, titanium, silver, silver chloride).
- the plurality of third electrodes 52 collectively function as a microfluidic switch, and the microfluidic switch may include any suitable type of conductor (e.g., platinum, chromium, titanium, etc.), any suitable type of insulating layer (e.g., silicon oxide, parylene, etc.), and any suitable type of hydrophobic layer (e.g., a fluorocarbon hydrophobic layer).
- the fluidic channel 56 includes a first bubble 60 and a second bubble 62 . Each of the first and second bubbles 60 , 62 are movable, and are hydrodynamically connected to one another.
- the MEMS pressure sensor 18 is connected to the computing device 12 , and is configured for continuously measuring a tension level (e.g., a left ventricular wall tension level).
- the MEMS pressure sensor 18 may be any suitable type of MEMS pressure sensor.
- the MEMS pressure sensor 18 is configured as shown in FIG. 5 .
- the MEMS pressure sensor 18 includes a base 64 , a substrate 66 , and a pressure sensing membrane 68 .
- the membrane 68 includes a base layer 70 , a piezoresistive sensing member 72 , a wire lead 74 , and a metal layer 76 .
- the MEMS pH sensor 14 and the MEMS pressure sensor 18 may be incorporated into a single MEMS device.
- the communication system 16 is connected to the computing device 12 , and is configured for sending information from the implantable device 10 .
- the communication system 16 may be any suitable type of communication system.
- the communication system 16 is configured as shown in FIG. 6 .
- the communication system 16 includes a transmitter 78 connected to the computing device 12 .
- the transmitter 78 may be any suitable type of transmitter.
- the transmitter 78 is a radio-frequency transmitter.
- the transmitter 78 is a volume conduction transmitter.
- the transmitter 78 includes a volume conduction antenna 80 (see FIG. 7 ).
- the volume conduction antenna 80 may be any suitable type of volume conduction antenna, and may have any suitable shape.
- the volume conduction antenna 80 may be configured as shown in FIG. 7 .
- the volume conduction antenna 80 is a dipole antenna which includes a first pole 82 and a second pole 84 .
- Each of the first and second poles 82 , 84 includes a conductive layer 86 , and an insulating layer 88 connected to the conducting layer 86 . As the shorting paths between the two poles 82 , 84 are blocked by the respective insulating layers 88 , current is forced to flow along much longer paths, thereby significantly enhancing the far-field which contributes to the transmission of information from the volume conduction antenna 80 .
- the communication system 16 is also configured for receiving information sent to the implantable device 10 .
- the communication system 16 either includes a receiver (not shown) in addition to the transmitter 78 , or a transceiver 90 in lieu of the transmitter 78 as shown in FIG. 8 .
- the analysis module 20 is configured for determining the existence of organ ischemia based at least in part on one or more of the pH values of the organ (e.g., heart, brain, liver, kidney, lung, etc.) measured by the MEMS pH sensor 14 . According to various embodiments, the analysis module 20 is further configured for determining the existence of organ ischemia based at least in part on one or more of the measured organ pH values and one or more of the left ventricular wall tension values measured by the MEMS pressure sensor 18 .
- the analysis module 20 may be implemented in hardware, firmware, software and combinations thereof.
- the software may utilize any suitable computer language (e.g., C, C++, Java, JavaScript, Visual Basic, VBScript, Delphi) and may be embodied permanently or temporarily in any type of machine, component, physical or virtual equipment, storage medium, or propagated signal capable of delivering instructions to a device.
- the analysis module 20 e.g., software application, computer program
- the analysis module 20 may reside at the computing device 12 , at another component of the implantable device 10 , or combinations thereof.
- the analysis module 20 may be distributed across two or more computing devices 12 .
- the power source 22 is configured to provide power to the components of the implantable device 10 , and is connected to the computing device 12 .
- the power source 22 may be any suitable type of power source.
- the power source 22 may be a rechargeable battery, a non-rechargeable battery, etc.
- FIG. 9 illustrates various embodiments of a system 100 .
- the system 100 may be utilized for the detection of organ ischemia.
- the system 100 may be utilized to detect ischemia of a heart, a brain, a liver, a kidney, a lung, etc.
- the system 100 may also be utilized for the treatment of organ ischemia (e.g., treatment of myocardial ischemia).
- the system 100 includes the implantable device 10 of FIG. 1 , and also includes a communication device 102 communicably connected to the implantable device 10 .
- the communication device 102 is positioned external to the body, and may be communicably connected to the implantable device 10 in any suitable manner.
- the communication device 102 may be wirelessly connected to implantable device 10 via volume conduction, via radio frequency inductive coupling, etc.
- the system 100 may also include a power source 104 connected to the implantable device 10 , and a stimulator 106 connected to either the implantable device 10 or the communication device 102 .
- the communication device 102 may also be communicably connected to a network 108 having wired or wireless data pathways, and may also be communicably connected to a plurality of remote devices 110 (e.g., a device associated with emergency medical personnel) via the network 108 .
- the network 108 may include any type of delivery system including, but not limited to, a local area network (e.g., Ethernet), a wide area network (e.g.
- the Internet and/or World Wide Web may include elements, such as, for example, intermediate nodes, proxy servers, routers, switches, and adapters configured to direct and/or deliver data.
- the communication device 102 is configured to communicate with the remote devices 110 via the network 108 using various communication protocols (e.g., HTTP, TCP/IP, UDP, WAP, WiFi, Bluetooth) and/or to operate within or in concert with one or more other communications systems.
- various communication protocols e.g., HTTP, TCP/IP, UDP, WAP, WiFi, Bluetooth
- the communication device 102 is configured for receiving information sent from the implantable device 10 . According to various embodiments, the communication device 102 is also configured for sending information to the implantable device 10 .
- the communication device 102 may be any suitable type of communication device. For example, according to various embodiments, the communication device 102 is configured as shown in FIG. 10 .
- the communication device 102 includes a communication system 112 , a computing device 114 , and a power source 116 . As shown in FIG. 10 , according to various embodiments, the communication device 102 may also include the analysis module 20 (or portions thereof).
- the communication system 112 may be any suitable type of communication system.
- the communication system 112 is configured similar to the communication system 16 .
- the computing device 114 may be any suitable type of computing device.
- the computing device 114 is configured similar to the computing device 12 .
- the power source 116 may be any suitable type of power source.
- the power source 116 is configured similar to the power source 22 .
- the power source 104 of the system 100 is configured to provide power to the components of the implantable device 10 .
- the power source 104 may be any suitable type of power source.
- the power source 104 is a piezoelectric energy harvesting device configured for converting one or more body forces into electricity.
- the piezoelectric energy harvesting device may be any suitable type of piezoelectric energy harvesting device.
- the piezoelectric energy harvesting device 104 may be configured as shown in FIG. 11 or as shown in FIG. 12 .
- the piezoelectric energy harvesting device 104 of FIG. 11 includes a base 118 , a carrying layer 120 , a piezoelectric material 122 , a first electrode 124 , and a second electrode 126 . As shown in the top view portion of FIG. 11 , the first and second electrodes 124 , 126 are interdigitated.
- the piezoelectric energy harvesting device 104 of FIG. 12 includes a base 128 , a carrying layer 130 , a first electrode 132 , a piezoelectric material 134 , and a second electrode 136 .
- the power source 104 is a biofuel cell.
- the biofuel cell may be any suitable type of biofuel cell.
- the biofuel cell 104 may be configured as shown in FIG. 13 .
- the biofuel cell 104 couples the oxidation of a biofuel (e.g., glucose) to the reduction of molecular oxygen to water and outputs electricity.
- a biofuel e.g., glucose
- the power source 104 is a volume conduction energy delivery device.
- the volume conduction energy delivery device may be any suitable type of volume conduction energy delivery device.
- the volume conduction energy delivery device 104 may be configured as shown in FIG. 14 .
- the volume conduction energy delivery device 104 includes a plurality of electrodes 150 , a disposable pad 152 , a power source 154 (e.g., a battery), a printed circuit board 156 , and a connector 158 .
- the stimulator 106 is an implantable stimulator which is connected to the implantable device 10 and to a part of the body (e.g., a cardiac vagal nerve branch).
- the stimulator 106 is configured to deliver a current to the part of the body when the implantable device 10 applies a voltage across the stimulator 106 .
- the stimulator 106 may be any suitable type of stimulator.
- FIG. 15 illustrates various embodiments of a method 160 .
- the method 160 is implemented at least in part by a computing device, and may be implemented by the system 100 of FIG. 9 .
- the method 160 may be utilized, for the detection of organ ischemia.
- the method 160 may be utilized to detect ischemia of a heart, a brain, a liver, a kidney, a lung, etc.
- the method 160 may also be utilized for the treatment of organ ischemia (e.g., treatment of myocardial ischemia).
- the method 160 will be described in the context of its implementation by the system 100 of FIG. 9 for the detection and treatment of myocardial ischemia.
- the method 160 may be implemented by other systems and may be utilized for the detection and treatment of other types of organ ischemia.
- the implantable device 10 Prior to the start of the process, the implantable device 10 is implanted into a body in a manner which allows the MEMS pH sensor 14 to measure the myocardial pH. According to various embodiments, the implantation of the implantable device 10 also allows the MEMS pressure sensor 18 to measure the left ventricular wall tension of the heart.
- the stimulator 106 is implanted into the body in a manner which allows for its connection to the implantable device 10 and to one or more cardiac vagal nerve branches.
- the process starts at block 162 , where the MEMS pH sensor 14 and the MEMS pressure sensor 18 respectively measure the myocardial pH level and the left ventricular wall tension of the heart.
- the process at block 162 may be repeated any number of times on an on going basis, resulting in the MEMS pH sensor 14 and the MEMS pressure sensor 18 respectively measuring a sequence of myocardial pH levels and a sequence of left ventricular wall tensions.
- the process advances to block 164 , where the respective measured values are passed on to the computing device 12 . Due to the electrical connection between the MEMS pH sensor 14 and the computing device 12 , the measured myocardial pH values are passed on to the computing device 12 in real time. Similarly, due to the electrical connection between the MEMS pressure sensor 18 and the computing device 12 , the measured left ventricular wall tension values are passed on to the computing device 12 in real time.
- the process advances to block 166 , where the computing device 12 receives the measured myocardial pH values and the measured left ventricular wall tension values. From block 166 , the process advances to block 168 , where the analysis module 20 determines whether a myocardial ischemic condition exists based on one or more of the received myocardial pH values. As described hereinabove, the analysis module 20 may also make the determination based on a combination of one or more of the measured myocardial pH values and one or more of the received left ventricular wall tension values. The analysis module 20 may make this determination any number of times on an on going basis.
- the analysis module 20 may make this determination in any suitable manner. For example, according to various embodiments, the analysis module 20 may determine the existence of myocardial ischemia when the measured myocardial pH level drops below a certain threshold value (e.g., 7.3), when the measured myocardial pH level is decreasing at a rate which exceeds a certain threshold rate, etc.
- a certain threshold value e.g., 7.3
- the analysis module 20 may determine the existence of myocardial ischemia when the measured myocardial pH level drops below a certain threshold value and the measured left ventricular wall tension drops below a certain threshold value, when some combination of measured myocardial pH value and measured left ventricular wall tension value falls within a certain predetermined range, when the measured myocardial pH level is decreasing at a rate which exceeds a certain threshold rate and the measured left ventricular wall tension value is increasing at a rate which exceeds a certain threshold rate, etc.
- the analysis module 20 prior to the determination by the analysis module 20 , the measured myocardial pH values and if applicable, the measured left ventricular wall tension values, are stored at the storage device 26 .
- the analysis module 20 accesses the stored values, either directly or via the processor 24 , to make the determination as to whether or not the values indicate the existence of organ ischemia.
- the analysis module 20 makes the determination as the measured values are received by the computing unit.
- the process returns to block 162 or advances to block 170 . If the determination made at block 168 is a determination that the measured myocardial pH values and/or the measured left ventricular wall tension values are not indicative of myocardial ischemia, the process returns to block 162 , where the process advances as described above.
- the process described for blocks 162 - 168 may be repeated any number of times.
- the process advances from block 168 to block 170 .
- the implantable device 10 sends a signal (e.g., an alert signal) to the communication device 102 , which may in turn send a signal (e.g., an alert signal) to one or more remote devices 110 to alert the appropriate personnel of the organ ischemia.
- the process advances to block 172 , where a voltage is applied across the stimulator 106 .
- the voltage may be applied for any period of time, and may be applied as a series of pulses at a predetermined frequency.
- the application of the voltage stimulates the cardiac vagal nerve branches, which in turn increases the parasympathetic tone.
- the increase in the parasympathetic tone operates to reduce the myocardial oxygen consumption, which in turn allows for the re-establishment of myocardial biochemical homeostasis.
- the voltage is applied across the stimulator 106 by the implantable device 10 .
- the voltage is applied across the stimulator 106 by the communication device 102 .
- the process advances to block 174 , where the analysis module 20 determines whether myocardial pH values and/or the left ventricular wall tension values measured after the start of the application of the voltage across the stimulator 106 are indicative of myocardial ischemia. From block 174 , the process returns to block 172 or advances to block 176 . If the determination made at block 174 is a determination that the myocardial pH values and/or the left ventricular wall tension values measured after the start of the application of the voltage across the stimulator 106 are indicative of myocardial ischemia, the process returns to block 172 , where the process advances as described above. The process described for blocks 172 - 174 may be repeated any number of times. In general, the application of the voltage will continue as long as the measured myocardial pH values and/or the measured left ventricular wall tension values are indicative of myocardial ischemia.
- the process advances from block 174 to block 176 .
- the voltage being applied across the stimulator 106 is disconnected. From block 176 , the process returns to block 162 , where the process advances as described above.
Abstract
An implantable device. The implantable device includes a computing device, a microelectromechanical system (MEMS) pH sensor connected to the computing device, and a communication system connected to the computing device.
Description
- This application claims the benefit of the earlier filing date of U.S. Patent Provisional Application No. 60/969,415 filed on Aug. 31, 2007.
- This application discloses an invention which is related, generally and in various embodiments, to an implantable device, a system including the implantable device, and a method utilizing the implantable device.
- Under a variety of circumstances, human organs (e.g., heart, brain, liver, kidney, lung, etc.) can become at risk for ischemia. For example, acute coronary syndromes include a spectrum of conditions associated with acute myocardial ischemia. These conditions are a major cause of morbidity and mortality around the world. Often, the signs and symptoms related to acute coronary syndromes occur without warning. One such symptom, angina pectoris, occurs when an area of the heart does not receive enough oxygen-rich blood. For patients with angina pectoris, the patients commonly mistake the symptoms for gastric acid reflux, indigestion, arthritic pain, etc. In other instances, the signs and symptoms related to acute coronary syndromes are not even perceived by the person—the signs and symptoms are “silent”.
- Unfortunately, the mistaken diagnosis or the lack of apparent symptoms often delays referral to a hospital emergency department for prompt treatment. Without timely and aggressive pharmacological and device-based therapy, acute coronary syndromes often evolve into myocardial infarction, eventually leading to serious complications including myocardial cell death, ventricular arrhythmias, heart failure, and death. Similarly, other types of organ ischemia also often lead to serious complications.
- It is generally accepted that patients treated in the first hour following the onset of myocardial ischemia have the highest absolute and relative mortality benefit. Thus, it is beneficial to detect impending acute coronary syndromes, and to provide suitable treatment prior to the occurrences of the symptoms. Similarly, it is beneficial to detect other types of impending organ ischemia and provide suitable treatment as early as possible.
- For a patient who experiences acute coronary syndromes, makes it to the hospital, and survives, a device may be surgically implanted to monitor pressures within the circulatory system (e.g., within an abdominal aortic aneurysm sac). Although such monitoring provides a certain peace of mind, the device is less than optimal because it does not predict the occurrence of subsequent acute coronary syndromes, and does not provide any treatment of such subsequent acute coronary syndromes.
- In one general respect, this application discloses an implantable device. According to various embodiments, the implantable device includes a computing device, a microelectromechanical system (MEMS) pH sensor connected to the computing device, and a communication system connected to the computing device.
- In another general respect, this application discloses a system. According to various embodiments, the system includes an implantable device, and a communication device connected to the implantable device. The implantable device includes a computing device, a microelectromechanical system (MEMS) pH sensor connected to the computing device, and a communication system connected to the computing device.
- In yet another general respect, this application discloses a method, implemented at least in part by a computing device. According to various embodiments, the method includes measuring pH values of an organ with an implanted device, and determining whether organ ischemia exists based on at least one of the measured pH values.
- Aspects of the invention may be implemented by a computing device and/or a computer program stored on a computer-readable medium. The computer-readable medium may comprise a disk, a device, and/or a propagated signal.
- Various embodiments of the invention are described herein in by way of example in conjunction with the following figures, wherein like reference characters designate the same or similar elements.
-
FIG. 1 illustrates various embodiments of an implantable device; -
FIG. 2 illustrates various embodiments of a computing device of the implantable device ofFIG. 1 ; -
FIG. 3 illustrates various embodiments of a MEMS pH sensor of the implantable device ofFIG. 1 ; -
FIG. 4 illustrates various embodiments of a MEMS pH sensor of the implantable device ofFIG. 1 ; -
FIG. 5 illustrates various embodiments of a MEMS pressure sensor of the implantable device ofFIG. 1 ; -
FIG. 6 illustrates various embodiments of a communication system of the implantable device ofFIG. 1 ; -
FIG. 7 illustrates various embodiments of a volume conduction antenna of the communication system ofFIG. 5 ; -
FIG. 8 illustrates various embodiments of a communication system of the implantable device ofFIG. 1 ; -
FIG. 9 illustrates various embodiments of a system which includes the implantable device ofFIG. 1 ; -
FIG. 10 illustrates various embodiments of a communication device of the system ofFIG. 9 ; -
FIG. 11 illustrates various embodiments of a power source of the system ofFIG. 9 ; -
FIG. 12 illustrates various embodiments of a power source of the system ofFIG. 9 ; -
FIG. 13 illustrates various embodiments of a power source of the system ofFIG. 9 ; -
FIG. 14 illustrates various embodiments of a power source of the system ofFIG. 9 ; and -
FIG. 15 illustrates various embodiments of a method which utilizes the implantable device ofFIG. 1 . - It is to be understood that at least some of the figures and descriptions of the invention have been simplified to illustrate elements that are relevant for a clear understanding of the invention, while eliminating, for purposes of clarity, other elements that those of ordinary skill in the art will appreciate may also comprise a portion of the invention. However, because such elements are well known in the art, and because they do not facilitate a better understanding of the invention, a description of such elements is not provided herein.
-
FIG. 1 illustrates various embodiments of animplantable device 10. Theimplantable device 10 is of a size and configuration which is suitable for implantation on an organ (e.g., heart, brain, liver, kidney, lung, etc.), and may be implanted using a minimally invasive technique. Theimplantable device 10 may be utilized for the detection and treatment of organ ischemia. Theimplantable device 10 includes acomputing device 12, a microelectromechanical system (MEMS)pH sensor 14, and acommunication system 16. As shown inFIG. 1 , according to various embodiments, theimplantable device 10 may also include aMEMS pressure sensor 18, ananalysis module 20, and apower source 22. - The
computing device 12 may be any suitable type of computing device. For example, according to various embodiments, thecomputing device 12 is configured as shown inFIG. 2 . For such embodiments, thecomputing device 12 includes aprocessor 24. Theprocessor 24 may be any suitable type of processor (e.g., a microprocessor, a digital signal processor, etc.). As shown inFIG. 2 , according to various embodiments, thecomputing device 12 also includes astorage device 26. Thestorage device 26 may be any suitable type of storage device. According to various embodiments, thecomputing device 12 is configured for direct memory access. - The
MEMS pH sensor 14 is connected to thecomputing device 12, and is configured for continuously measuring a pH level (e.g., a pH level of an organ). TheMEMS pH sensor 14 may be any suitable type of MEMS pH sensor. For example, according to various embodiments, theMEMS pH sensor 14 is configured as shown inFIG. 3 . For such embodiments, theMEMS pH sensor 14 includes asubstrate 28, afirst electrode 30, asecond electrode 32, a firstdielectric layer 34, athird electrode 36, a seconddielectric layer 38, anelectrolyte layer 40, apassivation layer 42, and aliquid junction 44. Theliquid junction 44 provides an electrical connection between theelectrolyte layer 40 and tissue fluid of the organ of which pH is to be measured (e.g., myocardial tissue fluid, brain tissue fluid, liver tissue fluid, kidney tissue fluid, lung tissue fluid, etc.). - The
first electrode 30 functions as an internal reference electrode, and may include any suitable type of conductor (e.g., gold). Thesecond electrode 32 functions as an indicator electrode, and may include any suitable type of conductor (e.g., iridium oxide). Thethird electrode 36 functions as a reference electrode, and may include any suitable type of conductor (e.g., silver, silver chloride). - According to other embodiments, the
MEMS pH sensor 14 is configured as shown inFIG. 4 . For such embodiments, theMEMS pH sensor 14 includes asubstrate 46, afirst electrode 48, asecond electrode 50, a plurality ofthird electrodes 52, acover 54, afluidic channel 56, and aliquid junction 58. The plurality ofthird electrodes 52 and thefluidic channel 56 cooperate to form a microfluidic switch. - The
first electrode 48 functions as an indicating electrode, and may include any suitable type of conductor (e.g., platinum, chromium, titanium, iridium oxide). Thesecond electrode 50 functions as a reference electrode, and may include any suitable type of conductor (e.g., platinum, chromium, titanium, silver, silver chloride). The plurality ofthird electrodes 52 collectively function as a microfluidic switch, and the microfluidic switch may include any suitable type of conductor (e.g., platinum, chromium, titanium, etc.), any suitable type of insulating layer (e.g., silicon oxide, parylene, etc.), and any suitable type of hydrophobic layer (e.g., a fluorocarbon hydrophobic layer). Thefluidic channel 56 includes afirst bubble 60 and asecond bubble 62. Each of the first andsecond bubbles - The
MEMS pressure sensor 18 is connected to thecomputing device 12, and is configured for continuously measuring a tension level (e.g., a left ventricular wall tension level). TheMEMS pressure sensor 18 may be any suitable type of MEMS pressure sensor. For example, according to various embodiments, theMEMS pressure sensor 18 is configured as shown inFIG. 5 . For such embodiments, theMEMS pressure sensor 18 includes abase 64, asubstrate 66, and apressure sensing membrane 68. As shown in the exploded portion ofFIG. 5 , according to various embodiments, themembrane 68 includes abase layer 70, apiezoresistive sensing member 72, awire lead 74, and ametal layer 76. As shown conceptually inFIG. 1 , theMEMS pH sensor 14 and theMEMS pressure sensor 18 may be incorporated into a single MEMS device. - The
communication system 16 is connected to thecomputing device 12, and is configured for sending information from theimplantable device 10. Thecommunication system 16 may be any suitable type of communication system. For example, according to various embodiments, thecommunication system 16 is configured as shown inFIG. 6 . For such embodiments, thecommunication system 16 includes atransmitter 78 connected to thecomputing device 12. - The
transmitter 78 may be any suitable type of transmitter. For example, according to various embodiments, thetransmitter 78 is a radio-frequency transmitter. According to other embodiments, thetransmitter 78 is a volume conduction transmitter. For embodiments where thetransmitter 78 is a volume conduction transmitter, thetransmitter 78 includes a volume conduction antenna 80 (seeFIG. 7 ). Thevolume conduction antenna 80 may be any suitable type of volume conduction antenna, and may have any suitable shape. For example, according to various embodiments, thevolume conduction antenna 80 may be configured as shown inFIG. 7 . For such embodiments, thevolume conduction antenna 80 is a dipole antenna which includes afirst pole 82 and asecond pole 84. Each of the first andsecond poles conductive layer 86, and an insulatinglayer 88 connected to theconducting layer 86. As the shorting paths between the twopoles layers 88, current is forced to flow along much longer paths, thereby significantly enhancing the far-field which contributes to the transmission of information from thevolume conduction antenna 80. - According to various embodiments, the
communication system 16 is also configured for receiving information sent to theimplantable device 10. For such embodiments, thecommunication system 16 either includes a receiver (not shown) in addition to thetransmitter 78, or atransceiver 90 in lieu of thetransmitter 78 as shown inFIG. 8 . - The
analysis module 20 is configured for determining the existence of organ ischemia based at least in part on one or more of the pH values of the organ (e.g., heart, brain, liver, kidney, lung, etc.) measured by theMEMS pH sensor 14. According to various embodiments, theanalysis module 20 is further configured for determining the existence of organ ischemia based at least in part on one or more of the measured organ pH values and one or more of the left ventricular wall tension values measured by theMEMS pressure sensor 18. Theanalysis module 20 may be implemented in hardware, firmware, software and combinations thereof. For embodiments utilizing software, the software may utilize any suitable computer language (e.g., C, C++, Java, JavaScript, Visual Basic, VBScript, Delphi) and may be embodied permanently or temporarily in any type of machine, component, physical or virtual equipment, storage medium, or propagated signal capable of delivering instructions to a device. The analysis module 20 (e.g., software application, computer program) may be stored on a computer-readable medium (e.g., disk, device, and/or propagated signal) such that when a computer reads the medium, the functions described herein are performed. - According to various embodiments, the
analysis module 20 may reside at thecomputing device 12, at another component of theimplantable device 10, or combinations thereof. For embodiments where theimplantable device 10 includes more than onecomputing device 12, theanalysis module 20 may be distributed across two ormore computing devices 12. - The
power source 22 is configured to provide power to the components of theimplantable device 10, and is connected to thecomputing device 12. Thepower source 22 may be any suitable type of power source. For example, according to various embodiments, thepower source 22 may be a rechargeable battery, a non-rechargeable battery, etc. -
FIG. 9 illustrates various embodiments of asystem 100. Thesystem 100 may be utilized for the detection of organ ischemia. For example, thesystem 100 may be utilized to detect ischemia of a heart, a brain, a liver, a kidney, a lung, etc. According to various embodiments, thesystem 100 may also be utilized for the treatment of organ ischemia (e.g., treatment of myocardial ischemia). Thesystem 100 includes theimplantable device 10 ofFIG. 1 , and also includes acommunication device 102 communicably connected to theimplantable device 10. Thecommunication device 102 is positioned external to the body, and may be communicably connected to theimplantable device 10 in any suitable manner. For example, thecommunication device 102 may be wirelessly connected toimplantable device 10 via volume conduction, via radio frequency inductive coupling, etc. As shown inFIG. 9 , according to various embodiments, thesystem 100 may also include apower source 104 connected to theimplantable device 10, and astimulator 106 connected to either theimplantable device 10 or thecommunication device 102. - As shown in
FIG. 9 , thecommunication device 102 may also be communicably connected to anetwork 108 having wired or wireless data pathways, and may also be communicably connected to a plurality of remote devices 110 (e.g., a device associated with emergency medical personnel) via thenetwork 108. Thenetwork 108 may include any type of delivery system including, but not limited to, a local area network (e.g., Ethernet), a wide area network (e.g. the Internet and/or World Wide Web), a telephone network (e.g., analog, digital, wired, wireless, PSTN, ISDN, GSM, GPRS, and/or xDSL), a packet-switched network, a radio network, a television network, a cable network, a satellite network, and/or any other wired or wireless communications network configured to carry data. Thenetwork 108 may include elements, such as, for example, intermediate nodes, proxy servers, routers, switches, and adapters configured to direct and/or deliver data. In general, thecommunication device 102 is configured to communicate with theremote devices 110 via thenetwork 108 using various communication protocols (e.g., HTTP, TCP/IP, UDP, WAP, WiFi, Bluetooth) and/or to operate within or in concert with one or more other communications systems. - The
communication device 102 is configured for receiving information sent from theimplantable device 10. According to various embodiments, thecommunication device 102 is also configured for sending information to theimplantable device 10. Thecommunication device 102 may be any suitable type of communication device. For example, according to various embodiments, thecommunication device 102 is configured as shown inFIG. 10 . For such embodiments, thecommunication device 102 includes acommunication system 112, acomputing device 114, and apower source 116. As shown inFIG. 10 , according to various embodiments, thecommunication device 102 may also include the analysis module 20 (or portions thereof). - The
communication system 112 may be any suitable type of communication system. For example, according to various embodiments, thecommunication system 112 is configured similar to thecommunication system 16. Thecomputing device 114 may be any suitable type of computing device. For example, according to various embodiments, thecomputing device 114 is configured similar to thecomputing device 12. Thepower source 116 may be any suitable type of power source. For example, according to various embodiments, thepower source 116 is configured similar to thepower source 22. - The
power source 104 of thesystem 100 is configured to provide power to the components of theimplantable device 10. Thepower source 104 may be any suitable type of power source. For example, according to various embodiments, thepower source 104 is a piezoelectric energy harvesting device configured for converting one or more body forces into electricity. The piezoelectric energy harvesting device may be any suitable type of piezoelectric energy harvesting device. For example, according to various embodiments, the piezoelectricenergy harvesting device 104 may be configured as shown inFIG. 11 or as shown inFIG. 12 . - The piezoelectric
energy harvesting device 104 ofFIG. 11 includes abase 118, acarrying layer 120, apiezoelectric material 122, afirst electrode 124, and asecond electrode 126. As shown in the top view portion ofFIG. 11 , the first andsecond electrodes energy harvesting device 104 ofFIG. 12 includes abase 128, acarrying layer 130, afirst electrode 132, apiezoelectric material 134, and asecond electrode 136. - According to other embodiments, the
power source 104 is a biofuel cell. The biofuel cell may be any suitable type of biofuel cell. For example, according to various embodiments, thebiofuel cell 104 may be configured as shown inFIG. 13 . For such embodiments, thebiofuel cell 104 couples the oxidation of a biofuel (e.g., glucose) to the reduction of molecular oxygen to water and outputs electricity. - According to other embodiments, the
power source 104 is a volume conduction energy delivery device. The volume conduction energy delivery device may be any suitable type of volume conduction energy delivery device. For example, according to various embodiments, the volume conductionenergy delivery device 104 may be configured as shown inFIG. 14 . For such embodiments, the volume conductionenergy delivery device 104 includes a plurality ofelectrodes 150, adisposable pad 152, a power source 154 (e.g., a battery), a printedcircuit board 156, and aconnector 158. - The
stimulator 106 is an implantable stimulator which is connected to theimplantable device 10 and to a part of the body (e.g., a cardiac vagal nerve branch). Thestimulator 106 is configured to deliver a current to the part of the body when theimplantable device 10 applies a voltage across thestimulator 106. Thestimulator 106 may be any suitable type of stimulator. -
FIG. 15 illustrates various embodiments of amethod 160. Themethod 160 is implemented at least in part by a computing device, and may be implemented by thesystem 100 ofFIG. 9 . Themethod 160 may be utilized, for the detection of organ ischemia. For example, themethod 160 may be utilized to detect ischemia of a heart, a brain, a liver, a kidney, a lung, etc. According to various embodiments, themethod 160 may also be utilized for the treatment of organ ischemia (e.g., treatment of myocardial ischemia). For ease of description purposes, themethod 160 will be described in the context of its implementation by thesystem 100 ofFIG. 9 for the detection and treatment of myocardial ischemia. However, it will be appreciated that themethod 160 may be implemented by other systems and may be utilized for the detection and treatment of other types of organ ischemia. - Prior to the start of the process, the
implantable device 10 is implanted into a body in a manner which allows theMEMS pH sensor 14 to measure the myocardial pH. According to various embodiments, the implantation of theimplantable device 10 also allows theMEMS pressure sensor 18 to measure the left ventricular wall tension of the heart. Thestimulator 106 is implanted into the body in a manner which allows for its connection to theimplantable device 10 and to one or more cardiac vagal nerve branches. - The process starts at
block 162, where theMEMS pH sensor 14 and theMEMS pressure sensor 18 respectively measure the myocardial pH level and the left ventricular wall tension of the heart. The process atblock 162 may be repeated any number of times on an on going basis, resulting in theMEMS pH sensor 14 and theMEMS pressure sensor 18 respectively measuring a sequence of myocardial pH levels and a sequence of left ventricular wall tensions. - From
block 162, the process advances to block 164, where the respective measured values are passed on to thecomputing device 12. Due to the electrical connection between theMEMS pH sensor 14 and thecomputing device 12, the measured myocardial pH values are passed on to thecomputing device 12 in real time. Similarly, due to the electrical connection between theMEMS pressure sensor 18 and thecomputing device 12, the measured left ventricular wall tension values are passed on to thecomputing device 12 in real time. - From
block 164, the process advances to block 166, where thecomputing device 12 receives the measured myocardial pH values and the measured left ventricular wall tension values. Fromblock 166, the process advances to block 168, where theanalysis module 20 determines whether a myocardial ischemic condition exists based on one or more of the received myocardial pH values. As described hereinabove, theanalysis module 20 may also make the determination based on a combination of one or more of the measured myocardial pH values and one or more of the received left ventricular wall tension values. Theanalysis module 20 may make this determination any number of times on an on going basis. - The
analysis module 20 may make this determination in any suitable manner. For example, according to various embodiments, theanalysis module 20 may determine the existence of myocardial ischemia when the measured myocardial pH level drops below a certain threshold value (e.g., 7.3), when the measured myocardial pH level is decreasing at a rate which exceeds a certain threshold rate, etc. According to other embodiments, theanalysis module 20 may determine the existence of myocardial ischemia when the measured myocardial pH level drops below a certain threshold value and the measured left ventricular wall tension drops below a certain threshold value, when some combination of measured myocardial pH value and measured left ventricular wall tension value falls within a certain predetermined range, when the measured myocardial pH level is decreasing at a rate which exceeds a certain threshold rate and the measured left ventricular wall tension value is increasing at a rate which exceeds a certain threshold rate, etc. - According to various embodiments, prior to the determination by the
analysis module 20, the measured myocardial pH values and if applicable, the measured left ventricular wall tension values, are stored at thestorage device 26. For such embodiments, theanalysis module 20 accesses the stored values, either directly or via theprocessor 24, to make the determination as to whether or not the values indicate the existence of organ ischemia. According to other embodiments, theanalysis module 20 makes the determination as the measured values are received by the computing unit. - From
block 168, the process returns to block 162 or advances to block 170. If the determination made atblock 168 is a determination that the measured myocardial pH values and/or the measured left ventricular wall tension values are not indicative of myocardial ischemia, the process returns to block 162, where the process advances as described above. The process described for blocks 162-168 may be repeated any number of times. - If the determination made at
block 168 is a determination that the measured myocardial pH values and/or the measured left ventricular wall tension values are indicative of myocardial ischemia, the process advances fromblock 168 to block 170. Atblock 170, theimplantable device 10 sends a signal (e.g., an alert signal) to thecommunication device 102, which may in turn send a signal (e.g., an alert signal) to one or moreremote devices 110 to alert the appropriate personnel of the organ ischemia. Fromblock 170, the process advances to block 172, where a voltage is applied across thestimulator 106. The voltage may be applied for any period of time, and may be applied as a series of pulses at a predetermined frequency. The application of the voltage stimulates the cardiac vagal nerve branches, which in turn increases the parasympathetic tone. The increase in the parasympathetic tone operates to reduce the myocardial oxygen consumption, which in turn allows for the re-establishment of myocardial biochemical homeostasis. For embodiments where thestimulator 106 is connected to theimplantable device 10, the voltage is applied across thestimulator 106 by theimplantable device 10. For embodiments where thestimulator 106 is connected to thecommunication device 102, the voltage is applied across thestimulator 106 by thecommunication device 102. - From
block 172, the process advances to block 174, where theanalysis module 20 determines whether myocardial pH values and/or the left ventricular wall tension values measured after the start of the application of the voltage across thestimulator 106 are indicative of myocardial ischemia. Fromblock 174, the process returns to block 172 or advances to block 176. If the determination made atblock 174 is a determination that the myocardial pH values and/or the left ventricular wall tension values measured after the start of the application of the voltage across thestimulator 106 are indicative of myocardial ischemia, the process returns to block 172, where the process advances as described above. The process described for blocks 172-174 may be repeated any number of times. In general, the application of the voltage will continue as long as the measured myocardial pH values and/or the measured left ventricular wall tension values are indicative of myocardial ischemia. - If the determination made at
block 174 is a determination that the myocardial pH values and/or the left ventricular wall tension values measured after the start of the application of the voltage across thestimulator 106 are not indicative of myocardial ischemia, the process advances fromblock 174 to block 176. Atblock 176, the voltage being applied across thestimulator 106 is disconnected. Fromblock 176, the process returns to block 162, where the process advances as described above. - Nothing in the above description is meant to limit the invention to any specific materials, geometry, or orientation of elements. Many part/orientation substitutions are contemplated within the scope of the invention and will be apparent to those skilled in the art. The embodiments described herein were presented by way of example only and should not be used to limit the scope of the invention.
- Although the invention has been described in terms of particular embodiments in this application, one of ordinary skill in the art, in light of the teachings herein, can generate additional embodiments and modifications without departing from the spirit of, or exceeding the scope of, the claimed invention. For example, many of the steps of the
method 90 may be performed concurrently. Accordingly, it is understood that the drawings and the descriptions herein are proffered only to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
Claims (31)
1. An implantable device, wherein the implantable device comprises:
a computing device;
a microelectromechanical system (MEMS) pH sensor connected to the computing device; and
a communication system connected to the computing device.
2. The implantable device of claim 1 , wherein the computing device is configured for applying a voltage across a stimulator connected to the implantable device.
3. The implantable device of claim 1 , wherein the MEMS pH sensor comprises:
a first electrode;
a second electrode formed on the first electrode;
a first dielectric layer formed on the first electrode;
a third electrode formed on the first dielectric layer;
a second dielectric layer formed on the third electrode;
an electrolyte layer formed on the third electrode; and
a liquid junction connected to the second dielectric layer.
4. The implantable device of claim 3 , wherein the MEMS pH sensor further comprises a passivation layer formed on the second dielectric layer.
5. The implantable device of claim 1 , wherein the MEMS pH sensor comprises a microfluidic switch.
6. The implantable device of claim 1 , wherein the MEMS pH sensor comprises:
a substrate;
a first electrode formed on the substrate;
a second electrode formed on the substrate;
a plurality of third electrodes formed on the substrate;
a cover connected to the substrate, wherein the cover defines a closed-loop fluidic channel between the substrate and a surface of the cover; and
a liquid junction connected to the cover.
7. The implantable device of claim 1 , wherein the communication system comprises at least one of the following:
a transmitter;
a receiver; and
a transceiver.
8. The implantable device of claim 1 , wherein the communication system comprises an antenna, wherein the antenna comprises:
a first pole, wherein the first pole comprises:
a first conductive layer; and
a first insulating layer connected to the first conductive layer; and
a second pole, wherein the second pole comprises:
a second conductive layer; and
a second insulating layer connected to the second conductive layer.
9. The implantable device of claim 1 , further comprising a microelectromechanical system (MEMS) pressure sensor connected to the computing device.
10. The implantable device of claim 9 , wherein the MEMS pressure sensor comprises a piezoresistive sensing member.
11. The implantable device of claim 1 , further comprising an analysis module configured for determining the existence of organ ischemia, wherein the determination is based on one or more pH values measured by the MEMS pH sensor.
12. The implantable device of claim 11 , wherein the determination is further based on one or more left ventricular wall tension values measured by a MEMS pressure sensor.
13. The implantable device of claim 1 , further comprising a power source connected to the computing device.
14. The implantable device of claim 13 , wherein the power source is a battery.
15. A system, comprising:
an implantable device, wherein the implantable device comprises:
a computing device;
a microelectromechanical system (MEMS) pH sensor connected to the computing device; and
a communication system connected to the computing device; and
a communication device connected to the implantable device.
16. The system of claim 15 , wherein the implantable device further comprises a microelectromechanical system (MEMS) pressure sensor connected to the computing device.
17. The system of claim 15 , wherein the communication device is wirelessly connected to the implantable device.
18. The system of claim 15 , wherein the communication device is configured for communication with at least one device other than the implantable device.
19. The system of claim 15 , further comprising a power source operatively connected to the implantable device.
20. The system of claim 19 , wherein the power source is a piezoelectric energy harvesting device.
21. The system of claim 19 , wherein the power source is a biofuel cell.
22. The system of claim 19 , wherein the power source is a volume conduction energy delivery device.
23. The system of claim 15 , further comprising a stimulator connected to the implantable device.
24. A method, implemented at least in part with a computing device, the method comprising:
measuring pH values of an organ with an implanted device; and
determining whether organ ischemia exists based on at least one of the measured pH values.
25. The method of claim 24 , wherein determining whether organ ischemia exists comprises determining whether the at least one of the measured pH values is less than a threshold value.
26. The method of claim 24 , further comprising sending an alert signal when it is determined that organ ischemia exists.
27. The method of claim 24 , further comprising measuring left ventricular wall tension values with the implanted device.
28. The method of claim 27 , wherein determining whether organ ischemia exists further comprises determining based on at least one of the measured left ventricular wall tension values.
29. The method of claim 28 , wherein determining whether organ ischemia exists further comprises determining whether the at least one of the measured left ventricular wall tension values is less than a threshold value.
30. The method of claim 24 , further comprising stimulating at least one cardiac vagal nerve branch when it is determined that organ ischemia exists.
31. The method of claim 30 , wherein stimulating the at least one cardiac vagal nerve branch comprises the implantable device applying a voltage across a stimulator connected to the implantable device and the at least one cardiac vagal nerve stimulator.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/203,041 US20090171413A1 (en) | 2007-08-31 | 2008-09-02 | Implantable device, system including same, and method utilizing same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96941507P | 2007-08-31 | 2007-08-31 | |
US12/203,041 US20090171413A1 (en) | 2007-08-31 | 2008-09-02 | Implantable device, system including same, and method utilizing same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090171413A1 true US20090171413A1 (en) | 2009-07-02 |
Family
ID=40387889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/203,041 Abandoned US20090171413A1 (en) | 2007-08-31 | 2008-09-02 | Implantable device, system including same, and method utilizing same |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090171413A1 (en) |
EP (1) | EP2195090A4 (en) |
JP (1) | JP2010537748A (en) |
AU (1) | AU2008292819A1 (en) |
CA (1) | CA2697686A1 (en) |
WO (1) | WO2009029943A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100140959A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Device and system for generation of power from intraluminal pressure changes |
US20100140957A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc | Method for generation of power from intraluminal pressure changes |
US20100141052A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc,A Limited Liability Corporation Of The State Of Delaware | System for powering devices from intraluminal pressure changes |
US20100140958A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for powering devices from intraluminal pressure changes |
US20100140943A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Device for storage of intraluminally generated power |
US20100140956A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc. | Method for generation of power from intraluminal pressure changes |
US20100298720A1 (en) * | 2009-04-16 | 2010-11-25 | Potkay Joseph Allen | In Situ Energy Harvesting Systems for Implanted Medical Devices |
US20100317929A1 (en) * | 2009-06-10 | 2010-12-16 | Bin Mi | Implantable medical devices with piezoelectric anchoring member |
US20100317978A1 (en) * | 2009-06-10 | 2010-12-16 | Maile Keith R | Implantable medical device housing modified for piezoelectric energy harvesting |
US20100317977A1 (en) * | 2009-06-10 | 2010-12-16 | Piaget Thomas W | Implantable medical device with internal piezoelectric energy harvesting |
WO2011062668A1 (en) * | 2009-11-19 | 2011-05-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Ph sensor |
FR2960156A1 (en) * | 2010-05-19 | 2011-11-25 | Laurent Berneman | Implantable electrode for use in cardiac pacemaker, has piezoelectric effect metal layer covered with thin film, where electrode is made of materials generating piezoelectric effect as primary or secondary energy source |
US8127618B1 (en) * | 2007-05-18 | 2012-03-06 | Pacesetter, Inc. | Implantable micro-electromechanical system sensor |
JP2013535995A (en) * | 2010-07-08 | 2013-09-19 | ティーシーアイ3 − プレッシャー アプリケーションズ, エルエルシー | System and method for monitoring compartment syndrome |
WO2013036600A3 (en) * | 2011-09-06 | 2014-05-15 | Phase2 Microtechnologies, Llc | Measurement device with reader and disposable probe |
JP2016105514A (en) * | 2010-12-22 | 2016-06-09 | アナログ ディヴァイスィズ インク | Vertically integrated system |
US20220110588A1 (en) * | 2020-10-14 | 2022-04-14 | California Institute Of Technology | Auto-powered synthetic skin |
EP4052643A1 (en) * | 2021-03-04 | 2022-09-07 | Universitat Pompeu Fabra | Implantable sensor for measuring and monitoring intravascular pressure, system comprising said sensor and method for operating thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2753923B8 (en) * | 2011-09-06 | 2017-12-20 | pHase2 Microtechnologies Inc. | Measurement device with sensor array |
JP6846701B2 (en) * | 2017-01-18 | 2021-03-24 | 国立研究開発法人産業技術総合研究所 | pH sensor and monitoring system |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4933048A (en) * | 1988-02-16 | 1990-06-12 | I-Stat Corporation | Reference electrode, method of making and method of using same |
US5199428A (en) * | 1991-03-22 | 1993-04-06 | Medtronic, Inc. | Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload |
US5573649A (en) * | 1991-03-20 | 1996-11-12 | Fujitsu Limited | Miniaturized oxygen electrode and process of producing same |
US6030358A (en) * | 1997-08-08 | 2000-02-29 | Odland; Rick Matthew | Microcatheter and method for site specific therapy |
US6419809B1 (en) * | 1999-06-24 | 2002-07-16 | Katayanagi Institute | Miniature reference electrode |
US20030013974A1 (en) * | 1998-08-07 | 2003-01-16 | Ananth Natarajan | Implantable myocardial ischemia detection, indication and action technology |
US20050288722A1 (en) * | 2002-09-26 | 2005-12-29 | Eigler Neal L | Implantable pressure transducer system optimized for anchoring and positioning |
US20060009811A1 (en) * | 2001-08-30 | 2006-01-12 | Sheldon Todd J | Ischemia detection |
US20060020300A1 (en) * | 2004-06-09 | 2006-01-26 | David Nghiem | Implantable medical device package antenna |
US20060178589A1 (en) * | 2005-02-07 | 2006-08-10 | Dobak John D Iii | Accelerometer-based monitoring of the frequency dynamics of the isovolumic contraction phase and pathologic cardiac vibrations |
US7160637B2 (en) * | 2003-05-27 | 2007-01-09 | The Regents Of The University Of California | Implantable, miniaturized microbial fuel cell |
US20070007285A1 (en) * | 2005-03-31 | 2007-01-11 | Mingui Sun | Energy delivery method and apparatus using volume conduction for medical applications |
US20070117243A1 (en) * | 2005-11-22 | 2007-05-24 | Manish Sharma | Method of fabricating a biosensor |
US20070156194A1 (en) * | 2005-12-30 | 2007-07-05 | Li Wang | Closed loop optimization of A-V and V-V timing |
US20070160748A1 (en) * | 2005-12-30 | 2007-07-12 | Schugt Michael A | Media-exposed interconnects for transducers |
US20080071190A1 (en) * | 2004-08-31 | 2008-03-20 | Gorodeski George I | Timing of Ovulation Based on Vaginal Ph |
US20080177194A1 (en) * | 2007-01-19 | 2008-07-24 | Cardiac Pacemakers, Inc. | Heart attack detector |
US20090024177A1 (en) * | 2007-07-18 | 2009-01-22 | Cardiac Pacemakers, Inc. | Osmometric Heart Monitoring Device and Methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6516808B2 (en) * | 1997-09-12 | 2003-02-11 | Alfred E. Mann Foundation For Scientific Research | Hermetic feedthrough for an implantable device |
US6201980B1 (en) * | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
WO2002058551A2 (en) | 2001-01-22 | 2002-08-01 | Integrated Sensing Systems, Inc. | Wireless mems capacitive sensor for physiologic parameter measurement |
ATE554824T1 (en) * | 2001-08-30 | 2012-05-15 | Medtronic Inc | DEVICE FOR DETECTING MYOCARDIAL ISCHEMIA |
-
2008
- 2008-09-02 US US12/203,041 patent/US20090171413A1/en not_active Abandoned
- 2008-09-02 CA CA2697686A patent/CA2697686A1/en not_active Abandoned
- 2008-09-02 AU AU2008292819A patent/AU2008292819A1/en not_active Abandoned
- 2008-09-02 EP EP08828139A patent/EP2195090A4/en not_active Withdrawn
- 2008-09-02 WO PCT/US2008/075050 patent/WO2009029943A1/en active Application Filing
- 2008-09-02 JP JP2010523199A patent/JP2010537748A/en active Pending
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4933048A (en) * | 1988-02-16 | 1990-06-12 | I-Stat Corporation | Reference electrode, method of making and method of using same |
US5573649A (en) * | 1991-03-20 | 1996-11-12 | Fujitsu Limited | Miniaturized oxygen electrode and process of producing same |
US5199428A (en) * | 1991-03-22 | 1993-04-06 | Medtronic, Inc. | Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload |
US6030358A (en) * | 1997-08-08 | 2000-02-29 | Odland; Rick Matthew | Microcatheter and method for site specific therapy |
US20030013974A1 (en) * | 1998-08-07 | 2003-01-16 | Ananth Natarajan | Implantable myocardial ischemia detection, indication and action technology |
US6419809B1 (en) * | 1999-06-24 | 2002-07-16 | Katayanagi Institute | Miniature reference electrode |
US20060009811A1 (en) * | 2001-08-30 | 2006-01-12 | Sheldon Todd J | Ischemia detection |
US20050288722A1 (en) * | 2002-09-26 | 2005-12-29 | Eigler Neal L | Implantable pressure transducer system optimized for anchoring and positioning |
US7160637B2 (en) * | 2003-05-27 | 2007-01-09 | The Regents Of The University Of California | Implantable, miniaturized microbial fuel cell |
US20060020300A1 (en) * | 2004-06-09 | 2006-01-26 | David Nghiem | Implantable medical device package antenna |
US20080071190A1 (en) * | 2004-08-31 | 2008-03-20 | Gorodeski George I | Timing of Ovulation Based on Vaginal Ph |
US20060178589A1 (en) * | 2005-02-07 | 2006-08-10 | Dobak John D Iii | Accelerometer-based monitoring of the frequency dynamics of the isovolumic contraction phase and pathologic cardiac vibrations |
US20070007285A1 (en) * | 2005-03-31 | 2007-01-11 | Mingui Sun | Energy delivery method and apparatus using volume conduction for medical applications |
US20070117243A1 (en) * | 2005-11-22 | 2007-05-24 | Manish Sharma | Method of fabricating a biosensor |
US20070156194A1 (en) * | 2005-12-30 | 2007-07-05 | Li Wang | Closed loop optimization of A-V and V-V timing |
US20070160748A1 (en) * | 2005-12-30 | 2007-07-12 | Schugt Michael A | Media-exposed interconnects for transducers |
US20080177194A1 (en) * | 2007-01-19 | 2008-07-24 | Cardiac Pacemakers, Inc. | Heart attack detector |
US20090024177A1 (en) * | 2007-07-18 | 2009-01-22 | Cardiac Pacemakers, Inc. | Osmometric Heart Monitoring Device and Methods |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8573062B2 (en) | 2007-05-18 | 2013-11-05 | Pacesetter, Inc. | Implantable micro-electromechanical system sensor |
US8127618B1 (en) * | 2007-05-18 | 2012-03-06 | Pacesetter, Inc. | Implantable micro-electromechanical system sensor |
US9631610B2 (en) | 2008-12-04 | 2017-04-25 | Deep Science, Llc | System for powering devices from intraluminal pressure changes |
US20100140958A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for powering devices from intraluminal pressure changes |
US20100140943A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Device for storage of intraluminally generated power |
US20100140956A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc. | Method for generation of power from intraluminal pressure changes |
US9759202B2 (en) | 2008-12-04 | 2017-09-12 | Deep Science, Llc | Method for generation of power from intraluminal pressure changes |
US20100140959A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Device and system for generation of power from intraluminal pressure changes |
US20100141052A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc,A Limited Liability Corporation Of The State Of Delaware | System for powering devices from intraluminal pressure changes |
US9567983B2 (en) | 2008-12-04 | 2017-02-14 | Deep Science, Llc | Method for generation of power from intraluminal pressure changes |
US9526418B2 (en) | 2008-12-04 | 2016-12-27 | Deep Science, Llc | Device for storage of intraluminally generated power |
US20100140957A1 (en) * | 2008-12-04 | 2010-06-10 | Searete Llc | Method for generation of power from intraluminal pressure changes |
US9353733B2 (en) | 2008-12-04 | 2016-05-31 | Deep Science, Llc | Device and system for generation of power from intraluminal pressure changes |
US20100298720A1 (en) * | 2009-04-16 | 2010-11-25 | Potkay Joseph Allen | In Situ Energy Harvesting Systems for Implanted Medical Devices |
US20100317978A1 (en) * | 2009-06-10 | 2010-12-16 | Maile Keith R | Implantable medical device housing modified for piezoelectric energy harvesting |
US20100317929A1 (en) * | 2009-06-10 | 2010-12-16 | Bin Mi | Implantable medical devices with piezoelectric anchoring member |
US8506495B2 (en) * | 2009-06-10 | 2013-08-13 | Cardiac Pacemakers, Inc. | Implantable medical devices with piezoelectric anchoring member |
US8777863B2 (en) * | 2009-06-10 | 2014-07-15 | Cardiac Pacemakers, Inc. | Implantable medical device with internal piezoelectric energy harvesting |
US20100317977A1 (en) * | 2009-06-10 | 2010-12-16 | Piaget Thomas W | Implantable medical device with internal piezoelectric energy harvesting |
EP2502060A4 (en) * | 2009-11-19 | 2013-05-08 | Univ Pittsburgh | Ph sensor |
EP2502060A1 (en) * | 2009-11-19 | 2012-09-26 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Ph sensor |
WO2011062668A1 (en) * | 2009-11-19 | 2011-05-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Ph sensor |
FR2982163A1 (en) * | 2010-05-19 | 2013-05-10 | Laurent Berneman | MUSCULAR STIMULATION DEVICE, ESPECIALLY CARDIAC STIMULATOR, COMPRISING ELECTRODES OPERATING BY PIEZOELECTRIC EFFECT |
FR2960156A1 (en) * | 2010-05-19 | 2011-11-25 | Laurent Berneman | Implantable electrode for use in cardiac pacemaker, has piezoelectric effect metal layer covered with thin film, where electrode is made of materials generating piezoelectric effect as primary or secondary energy source |
JP2013535995A (en) * | 2010-07-08 | 2013-09-19 | ティーシーアイ3 − プレッシャー アプリケーションズ, エルエルシー | System and method for monitoring compartment syndrome |
US10165956B2 (en) | 2010-07-08 | 2019-01-01 | TCI3—Pressure Applications LLC | Compartment syndrome monitoring systems and methods |
US9314175B2 (en) | 2010-07-08 | 2016-04-19 | TCI3—Pressure Applications, LLC | Compartment syndrome monitoring systems and methods |
JP2016105514A (en) * | 2010-12-22 | 2016-06-09 | アナログ ディヴァイスィズ インク | Vertically integrated system |
WO2013036600A3 (en) * | 2011-09-06 | 2014-05-15 | Phase2 Microtechnologies, Llc | Measurement device with reader and disposable probe |
US20220110588A1 (en) * | 2020-10-14 | 2022-04-14 | California Institute Of Technology | Auto-powered synthetic skin |
EP4052643A1 (en) * | 2021-03-04 | 2022-09-07 | Universitat Pompeu Fabra | Implantable sensor for measuring and monitoring intravascular pressure, system comprising said sensor and method for operating thereof |
WO2022184801A1 (en) * | 2021-03-04 | 2022-09-09 | Universitat Pompeu Fabra | Implantable sensor for measuring and monitoring intravascular pressure, system comprising said sensor and method for operating thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2697686A1 (en) | 2009-03-05 |
WO2009029943A9 (en) | 2009-05-22 |
AU2008292819A1 (en) | 2009-03-05 |
WO2009029943A1 (en) | 2009-03-05 |
EP2195090A4 (en) | 2010-09-01 |
JP2010537748A (en) | 2010-12-09 |
EP2195090A1 (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090171413A1 (en) | Implantable device, system including same, and method utilizing same | |
RU2756426C2 (en) | Method and system for obtaining and analyzing physiological data | |
US6198965B1 (en) | Acoustic telemetry system and method for monitoring a rejection reaction of a transplanted organ | |
US8744544B2 (en) | System having wireless implantable sensor | |
US8515559B2 (en) | Communication dipole for implantable medical device | |
EP2114525B1 (en) | Cardiac stimulator with an impedance measuring circuit for detecting ischemia | |
US8412352B2 (en) | Communication dipole for implantable medical device | |
EP2691019B1 (en) | Low power apparatus and method to measure complex electrical admittance or impedance | |
US5480420A (en) | Resorbable temporary medical electrode device | |
US10232184B2 (en) | Extracorporeal unit for inspecting the insulation of an electrical wire of an implanted medical device | |
Kaszala et al. | Device sensing: sensors and algorithms for pacemakers and implantable cardioverter defibrillators | |
WO2006017446A1 (en) | Device for estimating hematocrit | |
US20040210268A1 (en) | Apparatus for actively monitoring device for lead fixation in implantable tissue stimulators | |
EP2959937A1 (en) | Cuff electrode comprising a sensor and contacts for vagus nerve stimulation | |
EP1578247B1 (en) | Low power consumption implantable pressure sensor | |
WO2003015861A2 (en) | Electrostimulating device | |
US20050043639A1 (en) | Method for decreasing mortality of hemodialysis patients | |
US8209031B1 (en) | Implantable lead for measuring physiologic information | |
McAdams et al. | Low-cost, implantable wireless sensor platform for neuromodulation research | |
EP4059425B1 (en) | Detection and/or prediction of a medical condition using atrial fibrillation and glucose measurements | |
GB2563440B (en) | Securing a sensor at the heart | |
KR100996289B1 (en) | Electrode structure for physiological signals | |
Crenner et al. | Selective recording of thin muscular layers with improved Ag-AgCI electrodes | |
Stett et al. | Implantable bioelectronic interfaces for diagnosis, therapy and rehabilitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZENATI, MARCO;CLARK, WILLIAM W.;SCLABASSI, ROBERT J.;AND OTHERS;REEL/FRAME:022374/0041;SIGNING DATES FROM 20080912 TO 20090210 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |